AzTrials
AzTrials

Gastrostomy ComplicationsNCT07300865

Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children

A study testing 12 Fr gastrostomy tube/button and 14 Fr gastrostomy tube/button in people with Gastrostomy Complications and Gastrostomy Size, run by Therese Hössjer at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this interventional study is to compare two different sizes of a gastrostomy tube in children and the incidence of complications three months postoperatively. The study is questionnare-based and both the family and health care personel will fill in the formula about complications at the re-visit when the… Read more about this study

Who is it for?
Ages Up to 15 years
What is being tested?
12 Fr gastrostomy tube/button and 14 Fr gastrostomy tube/button
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteSweden
Study dates
20 Nov 2025to 1 Jan 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Scheduled for laparoscopic gastrostomy at Dep Pediatric Surgery Uppsala Akademiska University Hospital

Who cannot join

  • Any specific reasons to avoid one size or the other (children who are supposed to get mixed food or a special medication that can obstruate the tube will recieve a thicker tube)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Therese NL Hössjer, MD, PhD-student contact

+4618674613

therese.hossjer@uu.se

Johan Danielson, MD, Docent contact

+46186110000

johan.danielson@uu.se

Sweden1 site, 1 recruiting
  • Barnkirurgi/Pediatric surgery

    Uppsala, 75185

    Therese NL Hössjer, MD, PhD-student, 018674613, therese.hossjer@uu.se

    Johan Danielson, MD, Docent, therese.hossjer@uu.se

    Recruiting

Other trials in Sweden

About this study

The goal of this interventional study is to compare two different sizes of a gastrostomy tube in children and the incidence of complications three months postoperatively. The study is questionnare-based and both the family and health care personel will fill in the formula about complications at the re-visit when the tube is changed the first time at three months postoperatively. Complications requested are: granuloma, infection, pain, dislocation and leakage.

Read the detailed description

Project plan Does gastrostomy tube thickness affect incidence of complications?

Hypothesis A 12 Fr gastrostomy tube is associated with fewer complications than a 14 Fr tube.

Aim To investigate if the rate of postoperative complications is reduced when a 12 Fr gastrostomy is used instead of a 14 Fr.

Overview Placement of a gastrostomy is indicated in children with long term need of enteral nutrition where oral intake is inadequate and there is at least a partially functioning digestive tract [1]. The operative procedure includes creation of a channel through the stomach- and abdominal wall with placement of a tube. The tube keeps the channel open and enables feeding of and medication to the patient. There are different ways of establishing a gastrostomy: laparoscopic, percutaneous, radiologically assisted and open techniques. Some researchers consider the laparoscopic approach to be the most preferable and safe option while others prefer the percutaneous or open technique [2,3,4,5].

In Sweden approximately 300-400 children (0-18 years) receive a gastrostomy yearly, and it is one of the most common inpatient care interventions in children. The majority of patients have an underlying neurological disease with multiple somatic and/or cognitive impairments. Other indications include failure to thrive, nausea during cancer treatment, metabolic disorders, and gastrointestinal failure [6].

For most of the children and families the gastrostomy facilitates their everyday life and improve their well-being. Unfortunately, gastrostomies are associated with several minor complications which cause repeated contacts with healthcare providers in this already vulnerable patient group. Common complications are granuloma, infection, leakage, pain and dislocation, where granulomas are as common as 42-60% [3,4,7]. A granuloma, or granulation tissue, is formed in response to inflammation or a wound. It is a type of vascular connective tissue consisting of lymphoid cells, macrophages and plasma cells, which bleeds easily and produces exudate [8].

Today there is a lack of evidence on what size of gastrostomies should be used. Most commonly used thicknesses are 12 Fr and 14 Fr. One retrospective study showed that a 12 Fr gastrostomy tube were four times as likely to dislocate, than a 14 Fr gastrostomy [9]. In a previously published observational study we could not see that relation [10]. Instead, we found that a 12 Fr tube seems to be associated with fewer complications than other thicknesses. Since data seems to disperse, we aim to conduct this prospective randomised single-centre study to find out whether a 12 Fr tube thickness can reduce post-operative complications after gastrostomy compared to a 14 Fr.

Method

All children 0-15 years planned for a gastrostomy at Dep Pediatric Surgery in Uppsala will be invited to the study. After oral and written information, patient or caregivers will be asked to sign the form of consent. On the day of operation, the patient will be randomized to either 12 Fr or 14 Fr tube size of the gastrostomy. The surgeon will fill in the tube size in a questionary presented in appendix 2.1.

After three months the gastrostomy button should be changed to a new one, according to National guidelines for gastrostomies, which is done as an out patient visit at a nurse. Questionaries, including information about complications, will be filled out both by the nurse and the patient or caregivers.

The information from the three questionaries will be stored by the principal researcher at each clinic, and deidentified data will be filled out in an excel-file. The main researcher and doctoral student will then compile the data and perform statistical analyses. The results will be presented in a scientific journal.

Importance of project Gastrostomies are commonly encumbered with minor complications, and there is a lack of evidence and guidelines on what size of gastrostomy tube that should be used. Today, local traditions or the surgeons' choice, will determine the size of the gastrostomy tube. Previously done studies are few, and to our knowledge not randomized or prospective. This study will hopefully clear the question if the size matters.

References

  1. Braegger C, Decsi T, Dias JA, Hartman C, Kolacek S, Koletzko B, Koletzko S, Mihatsch W, Moreno L, Puntis J, Shamir R, Szajewska H, Turck D, van Goudoever J, ESPGHAN Committee on Nutrition (2010) Practical Approach to Paediatric Enteral Nutrition: A Comment by the ESPGHAN Committee on Nutrition. J Paediatr Gastroenterol Nutr 51(1):110-122
  2. Akay B, Capizzani TR, Lee AM, Drongowski RA, Geiger JD, Hirschl RB, Mychaliska GB (2010) Gastrostomy tube placement in infants and children: is there a preferred technique? J Ped Surg 45(6):1147-1152
  3. Jones VS, La Hei ER, Shun A (2007) Laparoscopic gastrostomy: the preferred method of gastrostomy in children. Pediatr Surg Int 23(11):1085-1089
  4. Angsten G, Danielson J, Kassa AM, Engstrand Lilja H (2015) Outcome of laparoscopic versus open gastrostomy in children. Pediatr Sug Int 31:1067-1072
  5. Merli L, De Marco EA, Fedele C, Mason EJ, Taddei A, Paradiso FV, Catania VD, Nanni L (2016) Gastrostomy Placement in children: Percutaneous Endoscopic Gastrostomy or Laparoscopic Gastrostomy? Surg Laparosc Endosc Percutan Tech 25(5):381-384
  6. Danielson J, Rutqvist J, Göthberg G, Arnbjörnsson E (2018) Gastrostomi hos barn - följ nationella riktlinjer. Läkartidningen 115:E6U6
  7. Franken J, Mauritz FA, Suksamanapun N, Hulsker CCC, van der See DC, van Herwaarden-Lindeboom MYA (2015) Efficacy and adverse events of laparoscopic gastrostomy placement in children: results of large cohort study. Surg Endosc 29:1545-1552
  8. Townley A, Wincentak J, Krog K, Schippke J, Kingsnorth S (2017) Paediatric gastrostomy stoma complications and treatments: A rapid scoping review. J Clin Nurs 27:1369-1380
  9. Jeziorczak PM, Frenette RS, Lee J, Coe SC, Aprahamian CJ (2021) Size Matters: Early Gastrostomy Tube Dislodgment in Children. J Laparoendosc Adv Surg Tech A Sep 6. doi: 10.1089/lap.2021.0352. Online ahead of print
  10. Hössjer T, Göthberg G, Arnbjörnsson E, Rutqvist J, Perris F, Bartik Z, Almström M, Backman T and Danielson J (2023) Complication rate after gastrostomy placement in children can be reduced by simple surgical steps. Acta Paediatr. 2023;00;1-8. https://doi.org/10.1111/apa.16792
Being tested
12 Fr gastrostomy tube/button, 14 Fr gastrostomy tube/button
Keywords
laparoscopic gastrostomy, complications, pediatric surgery, children, granuloma
Medical subject headings
Food Intolerance, Granuloma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 12 Fr gastrostomy tube/buttonDevice

    Also called 12 Fr

    Patients in this arm will recieve 12 Fr size gastrostomy tube/ button

  • 14 Fr gastrostomy tube/buttonDevice

    Also called 14 Fr

    Patients in this arm will recieve 14 Fr size gastrostomy tube/ button

Study groups in NCT07300865
Study groupRoleWhat they receive
Children recieving 12 Fr gastrostomy tubeOtherNot described
Receives: Device: 12 Fr gastrostomy tube/button
Children recieving 14 Fr gastrostomy tubeOtherNot described
Receives: Device: 14 Fr gastrostomy tube/button

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Granuloma

    Measured: 3 months postoperatively

  2. Infection

    Measured: 3 months postoperatively

  3. Observed pain by caretakers/health care personel

    Measured: 3 months postoperatively

  4. Dislocation

    Measured: 3 months postoperatively

  5. Leakage

    Measured: 3 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study start20 Nov 2025
  3. Primary completion1 Jan 2030 (estimated)
  4. Study completion1 Jan 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07300865
Sponsor's protocol ID
2025-03305-01
Other IDs
2025
Status last verified
Dec 2025
First submitted
20 Dec 2025
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 12 Fr gastrostomy tube/button and 14 Fr gastrostomy tube/button in people with Gastrostomy Complications and Gastrostomy Size, run by Therese Hössjer at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Therese NL Hössjer, MD, PhD-student (+4618674613, therese.hossjer@uu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Granuloma (time frame: 3 months postoperatively). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in